top of page
Potential threat of therapeutic monoclonal antibodies against snake venom

Content Editor: Dr. Tanya Tanu

January 30, 2024 at 12:30:00 PM

Snake Bites, Antibody-dependent enhancement of toxicity, Monoclonal Antibody

Content Editor: Dr. Tanya Tanu
  • Snake envenoming is among the Neglected Tropical Diseases, leading to significant mortality and disability in certain communities.

  • A recent study by Sorenson et al. published in Nature Communications suggests the causation of antibody-dependent enhancement of toxicity (ADET) by a potential therapeutic human monoclonal antibody.

  • This antibody was used to neutralize myotoxin-II from the pit viper Bothrops asper in representative mouse models, thereby increasing the toxin’s toxicity.

  • This report  ADET of a toxin in animal studies highlights the necessity of assessing even well-known antibody formats in preclinical models to avoid potential deleterious effects as exemplified in the present study.

Click here to read more.

bottom of page